NACI rapid response: Booster dose in long-term care residents and seniors living in other congregate settings

This statement contains NACI’s independent advice and recommendations, which are based upon the best current available scientific knowledge. This document is being disseminated for information purposes. People administering the vaccine should also be aware of the contents of the relevant product monograph. Recommendations for use and other information set out herein may differ from that set out in the product monographs of the Canadian manufacturers of the vaccines. Manufacturer(s) have sought approval of the vaccines and provided evidence as to its safety and efficacy only when it is used in accordance with the product monographs. NACI members and liaison members conduct themselves within the context of PHAC’s Policy on Conflict of Interest, including yearly declaration of potential conflict of interest.

Data and Resources

Additional Info

Field	Value
Last Updated	April 17, 2026, 19:38 (UTC)
Created	April 17, 2026, 19:38 (UTC)
criticality_level	[]
geographic_scope	[]
open_canada_collection	publication
open_canada_date_published	2021-09-28 00:00:00
open_canada_keywords	{"fr": ["Déclaration", "rapide", "CCNI", "Dose", "rappel", "résidents", "établissements", "soins", "longue", "durée", "aînés", "autres", "milieux", "collectifs", "COVID", "pandémie", "COVID-19", "Coronavirus", "Vaccins", "immunisation", "Comité", "consultatif", "national", "immunisation", "CCNI", "Déclarations", "publications", "Méthodologie", "Résumé", "données probantes", "Fardeau", "de la maladie", "Efficacité", "réelle", "immunogénicité", "vaccine", "ARNm", "contre", "la COVID-19", "doses", "rappel", "vaccins", "à ARNm", "résidents", "établissements", "soins", "longue", "durée", "aînés", "vivant", "autres", "milieux", "vie", "collectifs", "Considérations", "éthique", "équité", "Renseignements", "supplémentaires", "Recommandations", "Priorités", "recherche", "Références", "Acide", "ribonucléique", "messager", "ASPC", "Agence", "de la santé", "publique", "du Canada", "CCNI", "ÉÉFA", "Éthique", "équité", "faisabilité", "acceptabilité", "EP", "Efficacité", "potentielle", "ER", "Efficacité réelle", "ÉSLD", "Établissement", "soins", "longue durée", "IC", "Intervalle", "confiance", "GCESP", "Groupe", "consultatif", "matière", "éthique", "santé", "publique", "NIA", "National Institute on Ageing", "SRAS-CoV-2", "Coronavirus", "du syndrome", "respiratoire", "aigu", "sévère 2", "VP", "Variant", "préoccupant"], "en": ["pandemic", "COVID-19", "Coronavirus", "COVID", "NACI", "rapid", "response", "Booster", "dose", "long-term", "care", "residents", "seniors", "living", "other", "congregate", "settings", "Vaccines", "immunization", "National", "Advisory", "Committee", "Immunization", "Statements", "publications", "Methods", "Summary", "evidence", "Burden", "illness", "mRNA", "vaccine", "effectiveness", "immunogenicity", "booster", "doses", "mRNA", "LTC", "residents", "seniors", "living", "congregate", "Ethics", "equity", "considerations", "Additional", "information", "Recommendations", "Research", "priorities", "References", "Confidence interval", "EEFA", "Ethics", "Equity", "Feasibility", "Acceptability", "Long-term care", "messenger ribonucleic acid", "NIA", "National", "Institute", "Ageing", "PHAC", "Public", "Health", "Agency", "Canada", "PHECG", "ethics", "Consultative", "Group", "SARS-CoV-2", "Severe", "acute", "respiratory", "syndrome", "coronavirus 2", "VE", "Vaccine", "effectiveness", "VOC", "Variant on concern"]}
open_canada_subject	["health_and_safety"]
sensitivity_level	unrestricted
title_fr	Déclaration rapide du CCNI : Dose de rappel chez les résidents en établissements de soins de longue durée et les aînés vivant dans d’autres milieux de vie collectifs
update_frequency	unknown